454 



INDEX OF SUBJECTS 



Jensen's circinom;!, i;;.'^ 



k 



RulniNS. 151, iS(), 204, 205, 211) 

 Knee joinls, i8<S, 189 

 Koch phenomenon, 365 



Lecithin. ;5-:5 



Lethal culture filtrates: .S12 

 /}. lypliosiis. 312 

 meningococcns, i\\2 

 nentrahzation, 312 

 potency compared to that of active 



principles, 312 

 relation of phenomenon -pvoducin;:; 

 potency, 31 1 

 Lethal effect: of bacterial filtrates 

 upon mice: 249 

 partial sernni neutralii?ation, 2r,2 

 in reference to effect upon tumors, 

 249, 250, 251, 252, 253, 254, 255, 

 256 

 sensitization with bacteria, 254 

 of phenomenon-producing prepa- 

 rations: 25, 27, 28, 77. 91. 99- 

 131, 209, 230 

 serum protection, 99, 209 

 Lethal principles: 3'.'> 

 B. abortus, 315 

 B. lepisepticus, 315 

 meningococcus, 316 

 Spiroclieta pallida, 315 

 Vibrio cholerae, 315 

 Liposarcoma of guinea pigs, 186, 226 

 Liver: 154. 205 

 capillaries. 176 

 extract, 177, 194 

 Local immunity, 133, 178 

 Local perivascular preparation, 192 

 Local preparedness, 146 

 Local vascular preparation, it)2 

 Luetin reaction, 173 

 Lungs, 180, 186, 202, 205 

 Lymph nodes, 16, 164. 190 

 Lymphatics, 16, 18, 164 



M 



Mallein, 354- 359 

 Massage, 163 



Mechanism and nature of phenomenon 

 of local skin reactivity, 349 



Meninges, 192 

 Meningococcemia. 197 

 Meningococcus: 39*^ 

 active principles: 31 



Hesredka autolyzed cultuics, 34 

 defatted antigens, 34 

 egg medium, 34 

 in fluid media, 31 

 heated antigens, 34 

 skin-preparatory potency. 33 

 variations in potency of strains, 31 

 washed cells, 34 



in washings of agar cultures. 32, 131 

 antiserum, 398, 400, 401 

 indirect method of titrating phenome- 

 non-neutralizing antibodies in 

 serum, 402 

 lethal principles compared to phe- 

 nomenon-producing potency, 316 

 neutralization of toxic substances, 403 

 phenomenon-neutralizing antibodies: 

 in commercial sera, 400 

 in polyvalent sera, 402 

 preparation of clinical therapeutic 



serum, 404 

 serological specificity of active prin- 

 ciples, 399 

 serum therapy, 395 

 toxic substances, 403 

 infections, 371, 385 

 meningitis, 33. 371 

 reacting factors: 120 



auxiliary antibody, 120, 121, 122 

 neutralization by heterologous sera, 

 120, 121, 122 

 serological groups: 33 

 reacting potencv, 33 

 Methods of elicitation of phenome- 

 non of local skin reactivity: i8i3 

 adrenals, 191 

 appendix, 189 

 brain, 192 

 conjunctiva, 191 

 ear, 187 



gastric mucosa, 187 

 kidneys, denervated, 189 

 knee joints, 188, 189 

 liposarcoma of guinea pigs, 186 

 lungs, 186 

 lymph nodes, 190 

 meninges, 192 

 pancreas, 191 

 peritoneum, 187 

 pleural cavity, 189 



